focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
Strangely enough, this all hinged on whether they got FDA approval, which they now have.
I believe that they are almost there, as identified in todays RNS, the minute any arrangement is made over funding the next 12 months, this will go ballistic.
Over $1.01 now, this will move up in the US when LSE is closed, Gap up tomorrow.
They’ve spent many hundreds of Millions developing this, it’s fallen from $30.00 a share, a buck is extremely cheap, it’s going to get funded.
Yes, they need cash but this is a US driven stock, let’s see what the yanks make of the news.
The SP here will be dictated by them, they’ll raise funds in dollars, Mount Sinai is a big holder, they won’t want massive dilution.
Let’s see how it plays out.
I’ll keep my holding as it is.
Furthermore, I recall our CEO mentioning that they were increasing production through the appointment of a secondary manufacturer, and then potentially a third.
Suggests 2024 is really going to be a transformational year, and the numbers are going to get very interesting.
US listing more than overdue now, be nice to have it announced before the next big surge in BTC.
Meanwhile user number’s continuing to grow, I’m sensing some mega returns here for the patient, it’s certainly going to get volatile.
I’m still fascinated that someone like Eric Xu has found this Company and bought a 5% stake in it.